Brandywine Global Investment Management LLC boosted its position in Mylan NV (NASDAQ:MYL) by 1.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,000,252 shares of the company’s stock after buying an additional 32,292 shares during the quarter. Brandywine Global Investment Management LLC owned approximately 0.39% of Mylan worth $54,807,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of MYL. BlackRock Inc. lifted its position in Mylan by 2.6% in the fourth quarter. BlackRock Inc. now owns 39,965,771 shares of the company’s stock valued at $1,095,061,000 after purchasing an additional 1,018,811 shares during the last quarter. Vanguard Group Inc lifted its position in Mylan by 1.4% in the third quarter. Vanguard Group Inc now owns 35,774,112 shares of the company’s stock valued at $1,309,333,000 after purchasing an additional 506,649 shares during the last quarter. Pzena Investment Management LLC lifted its position in Mylan by 2.6% in the third quarter. Pzena Investment Management LLC now owns 21,657,877 shares of the company’s stock valued at $792,678,000 after purchasing an additional 542,725 shares during the last quarter. Bank of New York Mellon Corp lifted its position in Mylan by 8.7% in the third quarter. Bank of New York Mellon Corp now owns 10,226,277 shares of the company’s stock valued at $374,280,000 after purchasing an additional 818,059 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in Mylan by 15.0% in the fourth quarter. Geode Capital Management LLC now owns 7,875,204 shares of the company’s stock valued at $215,460,000 after purchasing an additional 1,026,731 shares during the last quarter. 83.01% of the stock is owned by institutional investors and hedge funds.
In other Mylan news, insider Paul Campbell sold 11,533 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $27.50, for a total value of $317,157.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.81% of the stock is currently owned by corporate insiders.
Several brokerages have weighed in on MYL. Cantor Fitzgerald reiterated a “hold” rating and issued a $41.00 price objective on shares of Mylan in a research report on Tuesday, November 20th. ValuEngine downgraded Mylan from a “sell” rating to a “strong sell” rating in a report on Wednesday, November 21st. Mizuho restated a “neutral” rating on shares of Mylan in a report on Thursday, January 31st. Wells Fargo & Co decreased their target price on Mylan from $40.00 to $33.00 and set an “outperform” rating for the company in a report on Wednesday, February 27th. Finally, BMO Capital Markets upped their target price on Mylan to $40.00 and gave the company an “outperform” rating in a report on Wednesday, February 27th. They noted that the move was a valuation call. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $40.72.
MYL opened at $28.09 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.39 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $14.49 billion, a price-to-earnings ratio of 6.13, a PEG ratio of 1.15 and a beta of 1.47. Mylan NV has a 12-month low of $26.00 and a 12-month high of $42.50.
Mylan (NASDAQ:MYL) last posted its quarterly earnings data on Tuesday, February 26th. The company reported $1.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.36 by ($0.06). The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.10 billion. Mylan had a return on equity of 19.06% and a net margin of 3.08%. Mylan’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.43 EPS. On average, equities analysts predict that Mylan NV will post 4.38 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Brandywine Global Investment Management LLC Raises Holdings in Mylan NV (MYL)” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2019/03/17/brandywine-global-investment-management-llc-raises-holdings-in-mylan-nv-myl.html.
Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.
Featured Article: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.